Cyclica has received a grant from the Bill & Melinda Gates Foundation to apply its AI-enabled drug discovery platform to new therapeutic options for multiple low-data biological targets. The end goal is to expand the range of accessible non-hormonal contraceptive choices for women in developing countries. … Read More
News round-up for 17-21 October by DDW Digital Content Editor Diana Spencer Amid continued concern about antibiotic resistance, the headline news this week was the discovery of a new antibiotic that could be effective against some of the most treatment-resistant pathogens. However, there was also… Read More
The first and only oral contraception containing a new, synthetic version of a naturally occurring oestrogen has been launched in the UK. Gedeon Richter’s Drovelis (14.2mg estetrol [E4] plus 3mg drospirenone [DRSP]) as a combined oral contraceptive is now available. The company cautions that any… Read More
Gedeon Richter has become marketing authorisation holder for Evra, a once-weekly contraception for women of fertile age, which they say is the first and only transdermal contraceptive patch licenced in the UK. Tamas Neubauer, Managing Director of UK and Ireland at Gedeon Richter, believes that the addition of a patch to their… Read More
